Intuitive Surgical, Inc. $ISRG Stock Position Trimmed by Robocap Asset Management Ltd

Robocap Asset Management Ltd lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 11,883 shares of the medical equipment provider’s stock after selling 2,659 shares during the quarter. Intuitive Surgical makes up approximately 6.0% of Robocap Asset Management Ltd’s investment portfolio, making the stock its 5th biggest holding. Robocap Asset Management Ltd’s holdings in Intuitive Surgical were worth $6,730,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. boosted its position in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $27,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.0%

Shares of NASDAQ:ISRG opened at $457.78 on Friday. The company has a market capitalization of $162.13 billion, a price-to-earnings ratio of 55.49, a price-to-earnings-growth ratio of 3.67 and a beta of 1.51. Intuitive Surgical, Inc. has a 52 week low of $427.84 and a 52 week high of $603.88. The firm has a 50 day moving average of $474.86 and a 200 day moving average of $516.55.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.81 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 421 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at approximately $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 5,906 shares of company stock valued at $2,907,726. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Piper Sandler dropped their target price on Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. dropped their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. UBS Group dropped their target price on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Evercore dropped their target price on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research report on Monday, April 6th. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $581.91.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.